Bachem to kick off New Year at Biotech Showcase™ San Francisco

Bubendorf, Switzerland: –The first event of 2025 for peptide and oligonucleotide manufacturers Bachem AG will be its appearance at the high-profile Biotech Showcase™ Investor Conference in San Francisco.

Bachem will send a team of three from Switzerland and its operation in California to connect with more than 3,200 biopharma leaders, including more than 1,000 investors, gathered at the Union Square San Francisco Hilton for a three-day program.

Life science innovators

First staged in 2008, the Biotech Showcase has established itself as an important starting point in the pharma and biotech calendar, as a networking and partnering conference that covers the full spectrum of life science innovation.

It will provide a platform for more than 350 early-stage and tech-driven biotech companies to showcase their latest innovations in the specialized TechBio Showcase and Seed Showcase presentation tracks. The conference is also likely to enable more than 6,000 one-on-one meetings between industry influencers and investors.

Representing Bachem at the Biotech Showcase will be Dr. Chris McGee, Bachem’s LA-based VP for Global Business Development, along with Riccardo Bernasconi, Director Business Development at Bachem AG, and Dr. Noah Duffy, Business Development Manager at Bachem USA.

About Bachem

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.

Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

For further information, see www.bachem.com

About Biotech Showcase™ 2025

Over 17 years, the Biotech Showcase™ Investor Conference has established itself as a premier networking and knowledge-sharing event for the life science industries. It has also become “the place to be to start the year” for biopharma industry decision-makers.

Seamlessly integrated with the TechBio and Seed Showcases that provide presentation platforms for industry start-ups and early-stage innovator companies, Biotech Showcase offers unmatched opportunities to engage with the full spectrum of life science innovation.

Biotech Showcase 2025 is a three-day event, opening January 13 at the Hilton San Francisco Union Square,

The event is jointly organized by Demy Colton and the EBD Group, with further details at: https://informaconnect.com/biotech-showcase/

Resources

Click on About the Biotech Showcase Program to see conference highlights.
Click on Bachem January 2025 Events for further information.
Click on Bachems News to see latest News & Events.